SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
abx137719-100tests |
Abbexa |
100 tests |
EUR 1237.5 |
Human IgG antibody Laboratories manufactures the sars-cov spike protein recombinant reagents distributed by Genprice. The Sars-Cov Spike Protein Recombinant reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Sars-Cov products are available in stock. Specificity: Sars-Cov Category: Spike Group: Protein Recombinant
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
FluoroSpot Path: SARS-CoV-2 (Spike) Human IgG |
Mabtech AB |
1 plate |
EUR 1176 |
SARS-CoV-2 Spike Protein IgG ELISA Kit |
Elabscience Biotech |
24 Tests |
Ask for price |
Description: Indirect |
SARS-CoV-2 Spike Protein IgG ELISA Kit |
Elabscience Biotech |
48 Tests |
Ask for price |
Description: Indirect |
SARS-CoV-2 Spike Protein IgG ELISA Kit |
Elabscience Biotech |
96 Tests |
EUR 500 |
Description: Indirect |
SARS-CoV-2 Spike Protein IgG ELISA Kit |
Elabscience Biotech |
96 Tests *10 |
EUR 5000 |
Description: Indirect |
Protein Recombinant information
Recombinant SARS-CoV Spike RBD protein |
MBS201279-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant SARS-CoV Spike RBD protein |
MBS201279-002mg |
MyBiosource |
0.02mg |
EUR 300 |
Recombinant SARS-CoV Spike RBD protein |
MBS201279-005mg |
MyBiosource |
0.05mg |
EUR 350 |
Recombinant SARS-CoV Spike RBD protein |
MBS201279-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Recombinant SARS-CoV Spike RBD protein |
MBS201279-025mg |
MyBiosource |
0.25mg |
EUR 805 |
Active Recombinant SARS-CoV Spike S1 Protein |
RP01302 |
Abclonal |
100μg |
EUR 42.25 |
|
Active Recombinant SARS-CoV Spike S1 Protein |
RP01309 |
Abclonal |
10μg |
EUR 162.5 |
|
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-109 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-111 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-118 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-300 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-107 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-207 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-209 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
21-805 |
ProSci |
50 ug |
EUR 468.6 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
21-807 |
ProSci |
50 ug |
EUR 437.1 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020). |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-117 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |